According to a recent LinkedIn post from Strive Health, the company is using National Kidney Month in March to spotlight the scale and complexity of chronic kidney disease in the U.S. The post cites an estimated 37 million Americans living with chronic kidney disease, many undiagnosed and often managing comorbidities such as diabetes or hypertension.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights early awareness, prevention and coordinated care as levers to improve outcomes for this large patient population. It also indicates that Strive intends to share resources, insights and stories that emphasize proactive, personalized and patient-centered value-based kidney care.
For investors, the post suggests Strive is positioning itself firmly within value-based care models targeting high-cost, high-need patients, which could align with payers’ and providers’ efforts to control chronic disease costs. The emphasis on education and thought leadership during a nationally recognized health month may also support brand visibility, potentially aiding future growth in partnerships and covered lives.

